We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

203 hedge funds and large institutions have $2.05B invested in Bio-Rad Laboratories Class A in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $353K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 62

3% more funds holding

Funds holding: 198 → 203 (+5)

4% more capital invested

Capital invested by funds: $1.97B → $2.05B (+$77.9M)

0.36% less ownership

Funds ownership: 75.05% → 74.69% (-0.36%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
203
Holders Change
+5
Holders Change %
+2.53%
% of All Funds
6.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
27
Increased
81
Reduced
62
Closed
20
Calls
$1.54M
Puts
$353K
Net Calls
+$1.19M
Net Calls Change
+$222K

Top Buyers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
+$29.6M
2
FWIA
Fort Washington Investment Advisors
Ohio
+$23.5M
3
LCS
Levin Capital Strategies
New York
+$15M
4
AI
Ariel Investments
Illinois
+$9.93M
5
Wells Fargo
Wells Fargo
California
+$9.55M

Top Sellers

Rank Fund Capital Flow
1
BBHC
Brown Brothers Harriman & Co
New York
-$72.6M
2
TCM
TimesSquare Capital Management
New York
-$26.2M
3
RA
Royce & Associates
New York
-$12.5M
4
BIT
BlackRock Institutional Trust
California
-$11.4M
5
CA
Commerzbank Aktiengesellschaft
Germany
-$11.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
GF
51
Gabelli Funds
New York
$6.45M – – –
SGA
52
Sector Gamma AS
Norway
$6.33M +$1.98M +16,800 +45%
DCM
53
Decade Capital Management
New York
$6.26M +$6.28M +53,220 New
OAM
54
Oxford Asset Management
United Kingdom
$6.13M -$851K -7,213 -12%
CCMLC
55
Cardinal Capital Management LLC (Connecticut)
Connecticut
$5.9M +$5.92M +50,216 New
Principal Financial Group
56
Principal Financial Group
Iowa
$5.84M -$45.9K -389 -0.8%
HCM
57
Highbridge Capital Management
New York
$5.8M +$1.36M +11,524 +30%
T. Rowe Price Associates
58
T. Rowe Price Associates
Maryland
$5.77M -$70.8K -600 -1%
PPA
59
Parametric Portfolio Associates
Washington
$5.77M +$232K +1,963 +4%
TAM
60
THB Asset Management
Connecticut
$5.6M +$407K +3,450 +8%
BCM
61
Breithorn Capital Management
New York
$5.55M +$30.7K +260 +0.6%
NFA
62
Nationwide Fund Advisors
Ohio
$5.35M +$1.38M +11,702 +35%
AIG
63
American International Group
New York
$5.03M -$46.9K -398 -0.9%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$4.33M +$139K +1,175 +3%
Deutsche Bank
65
Deutsche Bank
Germany
$4.26M -$3.08M -26,097 -42%
ARC
66
Absolute Return Capital
Massachusetts
$4.08M +$1.5M +12,709 +58%
Ohio Public Employees Retirement System (OPERS)
67
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.04M +$351K +2,975 +9%
Millennium Management
68
Millennium Management
New York
$3.96M -$2M -16,936 -33%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$3.87M -$1.18K -10 -0%
CS
70
Credit Suisse
Switzerland
$3.67M +$11.3K +96 +0.3%
State Board of Administration of Florida Retirement System
71
State Board of Administration of Florida Retirement System
Florida
$3.42M – – –
SIM
72
Spark Investment Management
New York
$3.2M – – –
ECM
73
EII Capital Management
New York
$3.15M – – –
Goldman Sachs
74
Goldman Sachs
New York
$3.11M +$1.93M +16,397 +163%
ERSOT
75
Employees Retirement System of Texas
Texas
$3.06M – – –
1 2
3
4 5

BIO Hedge Fund Activity: Q3 2013 in Review

203 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2013, worth a combined $2.05B — up 3.9% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BIO positions and 20 closed out — a net gain of 7 holders — while 81 added to existing stakes and 62 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $29.6M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $72.6M.

  • 203 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2013, up from 198 in Q2 2013.
  • Funds reported $2.05B of Bio-Rad Laboratories Class A stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 27 funds opened new Bio-Rad Laboratories Class A positions in Q3 2013 and 20 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2013 was American Century Companies, an estimated $29.6M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2013 was Brown Brothers Harriman & Co, an estimated $72.6M sold.

Based on aggregated 13F filings for Q3 2013.